IP Library Granted Patent US 10,655,167
Granted Patent B2
US 10,655,167 · App. 15/949,061 · Granted May 19, 2020

Ligase-assisted nucleic acid circularization and amplification

Inventors: Ryan Charles Heller (Amesbury, MA); Erik Leeming Kvam (Niskayuna, NY); John Richard Nelson (Niskayuna, NY)
Assignee: General Electric Company
C12Q1/6844C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,655,167
App. No.
15/949,061
Granted
May 19, 2020
Kind
B2
Abstract

Provided herein are methods for generation and amplification of a single-stranded DNA circle in a single reaction vessel from a linear DNA without any intervening purification steps. The single-stranded DNA circle is generated via a template-independent single-stranded DNA ligation. Whole-genome amplification of linear chromosomal DNA in a single tube using ligation-assisted DNA amplification is also provided.

Claims (20)

1. A method for nucleic acid amplification, the method comprising:

(a) ligating a linear chromosomal DNA to generate a single-stranded DNA circle; and

(b) amplifying the single-stranded DNA circle via rolling circle amplification using a random primer mixture to form an amplified DNA product,

wherein the random primer mixture comprises 2-amino-deoxyadenosine and 2-thio-deoxythymidine nucleotide analogs, and

wherein all the steps of the method are performed in a single reaction vessel without any intervening isolation or purification steps.

2. The method of claim 1 , wherein the random primer mixture comprises selective binding complementary oligonucleotides.

3. The method of claim 1 , wherein the random primer mixture further comprises a phosphorothioate modified nucleotide, a LNA nucleotide, or combinations thereof.

4. The method of claim 1 , wherein the linear chromosomal DNA is selected from the group consisting of a cell-free circulating DNA, a DNA isolated from a formalin fixed paraffin-embedded sample, a forensic DNA sample that has been exposed to environmental conditions, an ancient DNA sample, and combinations thereof.

5. The method of claim 1 , wherein the linear chromosomal DNA is a fragmented DNA.

6. The method of claim 1 , further comprising denaturing the linear chromosomal DNA to a single-stranded DNA prior to step (a), if the linear chromosomal DNA is in double-stranded form.

7. The method of claim 1 , wherein the ligase is selected from the group consisting of a TS2126 RNA ligase, a T4 RNA ligase, a T4 DNA ligase, a T3 DNA ligase, an E. coli DNA ligase, and combinations thereof.

8. The method of claim 7 , wherein the ligase is a pre-adenylated ligase.

9. The method of claim 8 , wherein the pre-adenylated ligase is a pre-adenylated TS2 126 RNA ligase.

10. The method of claim 1 , wherein the generation of the single-stranded DNA circle is performed in the absence of adenosine triphosphate or deoxyadenosine triphosphate.

11. The method of claim 1 , wherein steps (a) to (b) are performed in a sequential manner in the single reaction vessel.

12. The method of claim 1 , further comprising treating the linear chromosomal DNA with a polynucleotide kinase in the presence of a phosphate donor to generate a ligatable DNA sequence having a phosphate group at a 5′ terminal end and a hydroxyl group at a 3′ terminal end prior to incubating the linear chromosomal DNA with the ligase.

13. The method of claim 12 , wherein the linear chromosomal DNA is treated with the polynucleotide kinase in the presence of a phosphate donor other than adenosine triphosphate or deoxyadenosine triphosphate.

14. The method of claim 1 , further comprising sequencing the amplified DNA product.

15. The method of claim 6 , further comprising treating the single stranded DNA circles prior to step (b) to modify any damaged nucleobases.

16. The method of claim 1 , wherein the amplification is a whole genome amplification.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2020
From: GE HEALTHCARE UK LIMITED
To: GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS UK LTD
Reel/Frame 054300/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2020
From: GENERAL ELECTRIC COMPANY
To: GE HEALTHCARE UK LIMITED
Reel/Frame 053981/0329 →